Micell Technologies Receives CE Mark Approval for MiStent SES

07:11 EDT 12 Jun 2013 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
DURHAM, N.C., June 12, 2013 /PRNewswire/ -- Micell Technologies, Inc. received CE (Conformite Europeenne) Mark approval for its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) introducing a thin-strut stent that...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Micell Technologies Receives CE Mark Approval for MiStent SES"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story